Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02379949 · ClinicalTrials.gov registry record · NA
Virtual Reality Exposure Therapy for the Treatment of Social Phobia
A NA study of Social Anxiety Disorder, sponsored by Georgia State University.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
- 1
- Study location
NCT02379949: Completed NA study of Social Anxiety Disorder, sponsored by Georgia State University.
NCT02379949 is a NA study of Social Anxiety Disorder that has completed, run by Georgia State University. The registered enrollment target is 97 participants, below the 157-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02379949, a NA study of Social Anxiety Disorder, has completed, sponsored by Georgia State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial compares virtual reality exposure therapy to exposure group therapy to a waiting list control group.
Primary Outcome
30 true/false items measuring public speaking confidence across three dimensions: before, during, and after delivering a speech.
Conditions Studied
Interventions
- BEHAVIORAL Virtual Reality Exposure Therapy
- BEHAVIORAL Exposure Group Therapy
Study Locations (1)
Georgia
- Georgia State University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-08 |
| Phase | NA |
What the finished NCT02379949 record still lists
NCT02379949 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 97 participants, a relatively small participant target, below the 157-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Social Anxiety Disorder appearing as the primary indexed condition, and to 2 interventions - of which Virtual Reality Exposure Therapy is the first listed.
NCT02379949 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT02379949 about?
NCT02379949 is a clinical study titled "Virtual Reality Exposure Therapy for the Treatment of Social Phobia". This randomized clinical trial compares virtual reality exposure therapy to exposure group therapy to a waiting list control group.
What is the current status of trial NCT02379949?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2004-08. Estimated completion is 2007-08.
What conditions does trial NCT02379949 study?
This clinical trial studies the following conditions: Social Anxiety Disorder.
What interventions are being tested in trial NCT02379949?
The interventions under investigation include: Virtual Reality Exposure Therapy (BEHAVIORAL), Exposure Group Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02379949?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02379949 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Social Anxiety Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02379949's enrollment target sits among peer trials
97 17th of 32 higher than 16 of 32 other Social Anxiety Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Social Anxiety Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
-
Individual Factors of CBT Underlying Success
RECRUITING · NA
-
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
RECRUITING · NA
-
Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Attention Bias Modification Training for Social Phobia (ABMSP)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia